DA
GMAB icon

DCF Advisers’s Genmab GMAB Stock Holding History

DCF Advisers’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$535K Buy
+15,000
New +$474K 0.12% 82
2021
Q3 		– Sell
-10,000
Closed -$408K – 87
2021
Q2 		$408K Hold
10,000
– – 0.14% 74
2021
Q1 		$328K Hold
10,000
– – 0.14% 88
2020
Q4 		$407K Sell
10,000
-14,500
-59% -$542K 0.17% 75
2020
Q3 		$897K Buy
24,500
+12,000
+96% +$434K 0.46% 47
2020
Q2 		$424K Buy
+12,500
New +$341K 0.24% 60

Other funds holding GMAB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.4B AUM 32.2% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Eagle Global Advisors
Eagle Global Advisors Houston, Texas $3.02B AUM 27.86% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

DCF Advisers's GMAB Position: Q3 2026 in Review

DCF Advisers opened a new position in Genmab (GMAB) in Q3 2026: 15,000 shares worth $535K. The stake represents 0.12% of the portfolio and ranks #82 among its holdings. This is a return to the name: DCF Advisers previously reported a position in GMAB as recently as Q2 2021.

DCF Advisers first reported a position in GMAB in Q2 2020 and has held it in 6 quarters since. The position peaked at $897K in Q3 2020. 166 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • DCF Advisers held 15,000 shares of Genmab worth $535K as of Q3 2026.
  • Genmab was a new DCF Advisers position in Q3 2026.
  • Genmab made up 0.12% of DCF Advisers's portfolio in Q3 2026, its #82 holding.
  • DCF Advisers first reported a position in Genmab in Q2 2020 and has held it in 6 quarters since.
  • DCF Advisers's Genmab position peaked at $897K in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.